I am Zijian Deng, an instructor in the Department of Biomedical Engineering at UT Southwestern Medical Center, with a specialization in biomedical engineering, optical imaging and image-guided therapy. I graduated with the doctoral degree from Peking University, China. During my period of doctoral study, I devoted myself in photoacoustic imaging (PAI). I developed several innovative PAI systems for anatomical and functional imaging. To improve PAI contrast, I further accessed novel nanoparticles for in vivo tumor imaging. I joined Johns Hopkins University as a postdoctoral fellow in 2017, later moved to UT Southwestern in 2020, and was promoted to Instructor in 2021. In these periods, I have made great advances in optical tomography for pre-clinical cancer radiotherapy (RT). I first developed bioluminescence tomography (BLT) for tumor localization based on reconstructed center of mass or volume to guide conformal irradiation for reducing normal tissue involvement, which is expected to increase reproducibility of radiobiological discovery, and demonstrated them in an orthotopic glioblastoma model. I further advanced the BLT to quantify tumor growth, guide RT, and assess treatment outcomes for orthotopic pancreatic adenocarcinoma. These innovative technologies support the scientific community to accelerate advancements in cancer therapy.
I am Zijian Deng, an instructor in the Department of Biomedical Engineering at UT Southwestern Medical Center, with a specialization in biomedical engineering, optical imaging and image-guided therapy. I graduated with the doctoral degree from Peking University, China. During my period of doctoral study, I devoted myself in photoacoustic imaging (PAI). I developed several innovative PAI systems for anatomical and functional imaging. To improve PAI contrast, I further accessed novel nanoparticles for in vivo tumor imaging. I joined Johns Hopkins University as a postdoctoral fellow in 2017, later moved to UT Southwestern in 2020, and was promoted to Instructor in 2021. In these periods, I have made great advances in optical tomography for pre-clinical cancer radiotherapy (RT). I first developed bioluminescence tomography (BLT) for tumor localization based on reconstructed center of mass or volume to guide conformal irradiation for reducing normal tissue involvement, which is expected to increase reproducibility of radiobiological discovery, and demonstrated them in an orthotopic glioblastoma model. I further advanced the BLT to quantify tumor growth, guide RT, and assess treatment outcomes for orthotopic pancreatic adenocarcinoma. These innovative technologies support the scientific community to accelerate advancements in cancer therapy.